Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory OfficerGlobeNewsWire • Thursday
Disc Medicine: Hematological Disorders Treatment Advances With DISC-0974 ProgressSeeking Alpha • 06/14/24
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressGlobeNewsWire • 06/14/24
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 CongressGlobeNewsWire • 05/14/24
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor ConferenceGlobeNewsWire • 05/13/24
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 05/09/24
Top 3 Health Care Stocks You'll Regret Missing This Month - Humana (NYSE:HUM), Disc Medicine (NASDAQ:IRON)Benzinga • 04/02/24
Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity StudyInvestors Business Daily • 04/01/24
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)GlobeNewsWire • 04/01/24
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/21/24
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024GlobeNewsWire • 03/06/24
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial OfficerGlobeNewsWire • 02/26/24
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseGlobeNewsWire • 02/20/24
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia VeraGlobeNewsWire • 02/09/24
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating OfficerGlobeNewsWire • 02/07/24
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/24
Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory BoardGlobeNewsWire • 12/20/23
Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/12/23
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/11/23
Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with BitopertinGlobeNewsWire • 11/14/23